The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience
Urologists are commonly facing the dilemma of elevating prostate-specific antigen (PSA) levels despite a series of negative prostate biopsy results. Although fusion biopsies are being used increasingly, they are not available in many centers. We evaluated the prostate cancer detection rate using tra...
Gespeichert in:
| Veröffentlicht in: | Central European journal of urology 2019, Vol.72 (1), p.15-18 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 18 |
|---|---|
| container_issue | 1 |
| container_start_page | 15 |
| container_title | Central European journal of urology |
| container_volume | 72 |
| creator | Salagierski, Maciej Kania, Piotr Wierzchołowski, Wojciech Poźniak-Balicka, Róża |
| description | Urologists are commonly facing the dilemma of elevating prostate-specific antigen (PSA) levels despite a series of negative prostate biopsy results. Although fusion biopsies are being used increasingly, they are not available in many centers. We evaluated the prostate cancer detection rate using transperineal magnetic resonance imaging (MRI) template-guided cognitive biopsy.
Twenty-two patients with a suspicious lesion on MRI were enrolled into this study and underwent a repeated biopsy. All procedures were done under anesthesia and with antibiotic prophylaxis. Brachytherapy template was applied in each case.
The median age, PSA and prostate volume were 67 years, 9.2 ng/ml, and 65 ml, respectively. The average number of biopsy cores was 24. Nine patients (41%) were diagnosed with prostate cancer. The grade distribution was Gleason score 7 for 5 patients, and Gleason score 6 for 4 patients. No major complications occurred.
Transperineal MRI template-guided cognitive prostate biopsy appears to be a safe procedure, which helps to detect significant cancer. The biopsy-associated adverse events are negligible. |
| doi_str_mv | 10.5173/ceju.2018.1840 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2209946961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-1d6473ce902e3a0fe8bf8893f27ed7822a4b42b47474703a59e6c156d6928ea83</originalsourceid><addsrcrecordid>eNplUstu1DAUtRAVrUq3LJElNmwy-BXHYYGEqvKQKrFp15bj3Mx4lNjBdgr9nP4pjqaMoLUXvpLPOfd1EHpDyaamDf9gYb9sGKFqQ5UgL9AZI4pUQjX85TEm8hRdpLQn5UglZF2_QqecEkoFF2fo4WYHOIYRcBiwwRmmeTQZKpOSSxl6bMPWu-zuAOdofJohOg9mxHMMKRck7lyY031h2p13PxfAzuPZZAc-J_zL5R3uwLutP_Aj2PyM7SB9LMnnCKObnDfxHsPvNRN4C6_RyWDGBBeP7zm6_XJ1c_mtuv7x9fvl5-vKCqpyRXspGm6hJQy4IQOoblCq5QNroG8UY0Z0gnWiWS_hpm5BWlrLXrZMgVH8HH066M5LN0FvS_3RjHqObioF6WCc_v_Hu53ehjsthWwJlUXg_aNADGUOKevJJQvjaDyEJWnGKKeyLGHN9e4JdB-W6Et7BUXatihKWlCbA8qWaZXJDcdiKNGrAfRqAL0aQK8GKIS3_7ZwhP9dN_8D1pSxIw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2209946961</pqid></control><display><type>article</type><title>The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Salagierski, Maciej ; Kania, Piotr ; Wierzchołowski, Wojciech ; Poźniak-Balicka, Róża</creator><creatorcontrib>Salagierski, Maciej ; Kania, Piotr ; Wierzchołowski, Wojciech ; Poźniak-Balicka, Róża</creatorcontrib><description>Urologists are commonly facing the dilemma of elevating prostate-specific antigen (PSA) levels despite a series of negative prostate biopsy results. Although fusion biopsies are being used increasingly, they are not available in many centers. We evaluated the prostate cancer detection rate using transperineal magnetic resonance imaging (MRI) template-guided cognitive biopsy.
Twenty-two patients with a suspicious lesion on MRI were enrolled into this study and underwent a repeated biopsy. All procedures were done under anesthesia and with antibiotic prophylaxis. Brachytherapy template was applied in each case.
The median age, PSA and prostate volume were 67 years, 9.2 ng/ml, and 65 ml, respectively. The average number of biopsy cores was 24. Nine patients (41%) were diagnosed with prostate cancer. The grade distribution was Gleason score 7 for 5 patients, and Gleason score 6 for 4 patients. No major complications occurred.
Transperineal MRI template-guided cognitive prostate biopsy appears to be a safe procedure, which helps to detect significant cancer. The biopsy-associated adverse events are negligible.</description><identifier>ISSN: 2080-4806</identifier><identifier>ISSN: 2080-4873</identifier><identifier>EISSN: 2080-4873</identifier><identifier>DOI: 10.5173/ceju.2018.1840</identifier><identifier>PMID: 31011434</identifier><language>eng</language><publisher>Poland: Polish Urological Association</publisher><subject>Biopsy ; NMR ; Nuclear magnetic resonance ; Original Paper ; Prostate cancer ; Systematic review</subject><ispartof>Central European journal of urology, 2019, Vol.72 (1), p.15-18</ispartof><rights>Copyright Polish Urological Association 2019</rights><rights>Copyright by Polish Urological Association 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-1d6473ce902e3a0fe8bf8893f27ed7822a4b42b47474703a59e6c156d6928ea83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469016/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469016/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31011434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salagierski, Maciej</creatorcontrib><creatorcontrib>Kania, Piotr</creatorcontrib><creatorcontrib>Wierzchołowski, Wojciech</creatorcontrib><creatorcontrib>Poźniak-Balicka, Róża</creatorcontrib><title>The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience</title><title>Central European journal of urology</title><addtitle>Cent European J Urol</addtitle><description>Urologists are commonly facing the dilemma of elevating prostate-specific antigen (PSA) levels despite a series of negative prostate biopsy results. Although fusion biopsies are being used increasingly, they are not available in many centers. We evaluated the prostate cancer detection rate using transperineal magnetic resonance imaging (MRI) template-guided cognitive biopsy.
Twenty-two patients with a suspicious lesion on MRI were enrolled into this study and underwent a repeated biopsy. All procedures were done under anesthesia and with antibiotic prophylaxis. Brachytherapy template was applied in each case.
The median age, PSA and prostate volume were 67 years, 9.2 ng/ml, and 65 ml, respectively. The average number of biopsy cores was 24. Nine patients (41%) were diagnosed with prostate cancer. The grade distribution was Gleason score 7 for 5 patients, and Gleason score 6 for 4 patients. No major complications occurred.
Transperineal MRI template-guided cognitive prostate biopsy appears to be a safe procedure, which helps to detect significant cancer. The biopsy-associated adverse events are negligible.</description><subject>Biopsy</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Original Paper</subject><subject>Prostate cancer</subject><subject>Systematic review</subject><issn>2080-4806</issn><issn>2080-4873</issn><issn>2080-4873</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNplUstu1DAUtRAVrUq3LJElNmwy-BXHYYGEqvKQKrFp15bj3Mx4lNjBdgr9nP4pjqaMoLUXvpLPOfd1EHpDyaamDf9gYb9sGKFqQ5UgL9AZI4pUQjX85TEm8hRdpLQn5UglZF2_QqecEkoFF2fo4WYHOIYRcBiwwRmmeTQZKpOSSxl6bMPWu-zuAOdofJohOg9mxHMMKRck7lyY031h2p13PxfAzuPZZAc-J_zL5R3uwLutP_Aj2PyM7SB9LMnnCKObnDfxHsPvNRN4C6_RyWDGBBeP7zm6_XJ1c_mtuv7x9fvl5-vKCqpyRXspGm6hJQy4IQOoblCq5QNroG8UY0Z0gnWiWS_hpm5BWlrLXrZMgVH8HH066M5LN0FvS_3RjHqObioF6WCc_v_Hu53ehjsthWwJlUXg_aNADGUOKevJJQvjaDyEJWnGKKeyLGHN9e4JdB-W6Et7BUXatihKWlCbA8qWaZXJDcdiKNGrAfRqAL0aQK8GKIS3_7ZwhP9dN_8D1pSxIw</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Salagierski, Maciej</creator><creator>Kania, Piotr</creator><creator>Wierzchołowski, Wojciech</creator><creator>Poźniak-Balicka, Róża</creator><general>Polish Urological Association</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2019</creationdate><title>The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience</title><author>Salagierski, Maciej ; Kania, Piotr ; Wierzchołowski, Wojciech ; Poźniak-Balicka, Róża</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-1d6473ce902e3a0fe8bf8893f27ed7822a4b42b47474703a59e6c156d6928ea83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biopsy</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Original Paper</topic><topic>Prostate cancer</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salagierski, Maciej</creatorcontrib><creatorcontrib>Kania, Piotr</creatorcontrib><creatorcontrib>Wierzchołowski, Wojciech</creatorcontrib><creatorcontrib>Poźniak-Balicka, Róża</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Central European journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salagierski, Maciej</au><au>Kania, Piotr</au><au>Wierzchołowski, Wojciech</au><au>Poźniak-Balicka, Róża</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience</atitle><jtitle>Central European journal of urology</jtitle><addtitle>Cent European J Urol</addtitle><date>2019</date><risdate>2019</risdate><volume>72</volume><issue>1</issue><spage>15</spage><epage>18</epage><pages>15-18</pages><issn>2080-4806</issn><issn>2080-4873</issn><eissn>2080-4873</eissn><abstract>Urologists are commonly facing the dilemma of elevating prostate-specific antigen (PSA) levels despite a series of negative prostate biopsy results. Although fusion biopsies are being used increasingly, they are not available in many centers. We evaluated the prostate cancer detection rate using transperineal magnetic resonance imaging (MRI) template-guided cognitive biopsy.
Twenty-two patients with a suspicious lesion on MRI were enrolled into this study and underwent a repeated biopsy. All procedures were done under anesthesia and with antibiotic prophylaxis. Brachytherapy template was applied in each case.
The median age, PSA and prostate volume were 67 years, 9.2 ng/ml, and 65 ml, respectively. The average number of biopsy cores was 24. Nine patients (41%) were diagnosed with prostate cancer. The grade distribution was Gleason score 7 for 5 patients, and Gleason score 6 for 4 patients. No major complications occurred.
Transperineal MRI template-guided cognitive prostate biopsy appears to be a safe procedure, which helps to detect significant cancer. The biopsy-associated adverse events are negligible.</abstract><cop>Poland</cop><pub>Polish Urological Association</pub><pmid>31011434</pmid><doi>10.5173/ceju.2018.1840</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2080-4806 |
| ispartof | Central European journal of urology, 2019, Vol.72 (1), p.15-18 |
| issn | 2080-4806 2080-4873 2080-4873 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469016 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
| subjects | Biopsy NMR Nuclear magnetic resonance Original Paper Prostate cancer Systematic review |
| title | The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A43%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20a%20template-assisted%20cognitive%20transperineal%20prostate%20biopsy%20technique%20in%20patients%20with%20benign%20transrectal%20prostate%20biopsies:%20a%20preliminary%20experience&rft.jtitle=Central%20European%20journal%20of%20urology&rft.au=Salagierski,%20Maciej&rft.date=2019&rft.volume=72&rft.issue=1&rft.spage=15&rft.epage=18&rft.pages=15-18&rft.issn=2080-4806&rft.eissn=2080-4873&rft_id=info:doi/10.5173/ceju.2018.1840&rft_dat=%3Cproquest_pubme%3E2209946961%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2209946961&rft_id=info:pmid/31011434&rfr_iscdi=true |